{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:43:17Z","timestamp":1776087797731,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>This study investigated the expression of angiopoietin-like protein 2 (ANGPTL2) in the tissues of rat models of polycystic ovary syndrome (PCOS) and its correlation with PCOS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Six-weeks-old female specific pathogen-free rats (<jats:italic>n<\/jats:italic>\u2009=\u200960) were divided into blank control, PCOS model, and metformin groups (<jats:italic>n<\/jats:italic>\u2009=\u200920\/group). After 21\u2009days of metformin intervention, the serum sex hormones, fasting blood glucose, fasting insulin, and insulin resistance (IR) of rats in each group were measured. The mRNA levels of ANGPTL2, Foxol, and Akt in the ovarian tissues were monitored by real-time fluorescence quantitative PCR.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Compared with the control group, the levels of serum sex hormones, fasting blood glucose, fasting insulin, and IR in the model group showed significant increases, and the levels of ANGPTL2, Foxol, and Akt in the ovarian tissue also showed significant increases. Compared with the PCOS group, the serum sex hormones, fasting blood glucose, fasting insulin, and IR of rats in the metformin group were significantly decreased, and the levels of ANGPTL2, Foxol, and Akt in ovarian tissues also showed significant decreases.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These findings suggest that ANGPTL2 might participate in the development of PCOS through the PI3K\/Akt signaling pathway. Metformin improves IR by reducing the expression of ANGPTL2, thus improving the endocrine environment of PCOS and might change the disease outcome.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12958-020-00651-7","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T09:02:56Z","timestamp":1601283776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Expression of angiopoietin-like protein 2 in ovarian tissue of rat polycystic ovarian syndrome model and its correlation study"],"prefix":"10.1186","volume":"18","author":[{"given":"Dandan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-8065","authenticated-orcid":false,"given":"Yihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"651_CR1","doi-asserted-by":"publisher","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"3","key":"651_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/09513590.2011.583957","volume":"28","author":"DD Curi","year":"2012","unstructured":"Curi DD, Fonseca AM, Marcondes JA, Almeida JA, Bagnoli VR, Soares JM Jr, et al. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28(3):182\u20135. https:\/\/doi.org\/10.3109\/09513590.2011.583957.","journal-title":"Gynecol Endocrinol"},{"key":"651_CR3","doi-asserted-by":"publisher","unstructured":"Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;(2):Cd007506. https:\/\/doi.org\/10.1002\/14651858.CD007506.pub2.","DOI":"10.1002\/14651858.CD007506.pub2"},{"issue":"6","key":"651_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1365-2265.2011.03983.x","volume":"74","author":"J Joharatnam","year":"2011","unstructured":"Joharatnam J, Barber TM, Webber L, Conway GS, McCarthy MI, Franks S. Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. Clin Endocrinol. 2011;74(6):714\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.03983.x.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"651_CR5","first-page":"B5232","volume":"63","author":"D Glintborg","year":"2016","unstructured":"Glintborg D. Endocrine and metabolic characteristics in polycystic ovary syndrome. Dan Med J. 2016;63(4):B5232.","journal-title":"Dan Med J"},{"issue":"9","key":"651_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1507\/endocrj.ej12-0049","volume":"59","author":"W Li","year":"2012","unstructured":"Li W, Li Q. Dysregulation of glucose metabolism even in chinese pcos women with normal glucose tolerance. Endocr J. 2012;59(9):765\u201370. https:\/\/doi.org\/10.1507\/endocrj.ej12-0049.","journal-title":"Endocr J"},{"issue":"4","key":"651_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","volume":"42","author":"M Jensterle","year":"2017","unstructured":"Jensterle M, Goricar K, Janez A. Add on dpp-4 inhibitor alogliptin alone or in combination with pioglitazone improved beta-cell function and insulin sensitivity in metformin treated pcos. Endocr Res. 2017;42(4):261\u20138. https:\/\/doi.org\/10.1080\/07435800.2017.1294602.","journal-title":"Endocr Res"},{"issue":"11","key":"651_CR8","first-page":"1","volume":"2","author":"J Yang","year":"2011","unstructured":"Yang J, Wu Y, Wang Q. The chemical componets and pharmacological effect of fructus schisandrae and its application prospect. Biomirror. 2011;2(11):1\u201310.","journal-title":"Biomirror"},{"issue":"2","key":"651_CR9","first-page":"206","volume":"36","author":"Y Li","year":"2013","unstructured":"Li Y, Ma H, Xue J. Effects of polygala on the expression apoptosis-related proteins in hippocampus nerve cells of diabetic rats. Chin J Anat. 2013;36(2):206\u20139.","journal-title":"Chin J Anat"},{"issue":"3","key":"651_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clon.2012.11.003","volume":"25","author":"CE Coles","year":"2013","unstructured":"Coles CE, Donovan E, Haviland J, Yarnold J. Intensity-modulated radiotherapy for the treatment of breast cancer. Clin Oncol (R Coll Radiol). 2013;25(3):215. https:\/\/doi.org\/10.1016\/j.clon.2012.11.003.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"651_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jep.2009.08.022","volume":"126","author":"WS Shim","year":"2009","unstructured":"Shim WS, Back H, Seo EK, Lee HT, Shim CK. Long-term administration of an aqueous extract of dried, immature fruit of poncirus trifoliata (l.) raf. Suppresses body weight gain in rats. J Ethnopharmacol. 2009;126(2):294\u20139. https:\/\/doi.org\/10.1016\/j.jep.2009.08.022.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"651_CR12","first-page":"592","volume":"39","author":"D Zhou","year":"2017","unstructured":"Zhou D, Wu M, Zhao H. Heqi san combined with metformin for obese polycystic ovary syndrome (in chinese). Int J Trad Chin Med. 2017;39(7):592\u20136.","journal-title":"Int J Trad Chin Med"},{"key":"651_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13048-015-0192-9","volume":"8","author":"I Tessaro","year":"2015","unstructured":"Tessaro I, Modina SC, Franciosi F, Sivelli G, Terzaghi L, Lodde V, et al. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome. J Ovarian Res. 2015;8:64. https:\/\/doi.org\/10.1186\/s13048-015-0192-9.","journal-title":"J Ovarian Res"},{"issue":"13","key":"651_CR14","first-page":"3834","volume":"62","author":"M Dhanabal","year":"2002","unstructured":"Dhanabal M, LaRochelle WJ, Jeffers M, Herrmann J, Rastelli L, McDonald WF, et al. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res. 2002;62(13):3834\u201341.","journal-title":"Cancer Res"},{"issue":"2","key":"651_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet. 2002;30(2):151\u20137. https:\/\/doi.org\/10.1038\/ng814.","journal-title":"Nat Genet"},{"issue":"5","key":"651_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.modgep.2005.02.006","volume":"5","author":"Y Kubota","year":"2005","unstructured":"Kubota Y, Oike Y, Satoh S, Tabata Y, Niikura Y, Morisada T, et al. Isolation and expression patterns of genes for three angiopoietin-like proteins, angptl1, 2 and 6 in zebrafish. Gene Expr Patterns. 2005;5(5):679\u201385. https:\/\/doi.org\/10.1016\/j.modgep.2005.02.006.","journal-title":"Gene Expr Patterns"},{"issue":"3","key":"651_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bbrc.2012.11.127","volume":"430","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Kim JH, Kim JH, Martinus RD, Park SH. Angiopoietin-like protein 2, a chronic inflammatory mediator, is a new target induced by tgf-beta1 through a smad3-dependent mechanism. Biochem Biophys Res Commun. 2013;430(3):981\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2012.11.127.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"651_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (pcos): the hypothesis of pcos as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104.","journal-title":"Endocr Rev"},{"key":"651_CR19","doi-asserted-by":"publisher","unstructured":"Selen Alpergin ES, Bolandnazar Z, Sabatini M, Rogowski M, Chiellini G, Zucchi R, et al. Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine. Physiol Rep. 2017;5(1). https:\/\/doi.org\/10.14814\/phy2.13097.","DOI":"10.14814\/phy2.13097"},{"issue":"3","key":"651_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1095\/biolreprod.107.063610","volume":"78","author":"F Parborell","year":"2008","unstructured":"Parborell F, Abramovich D, Tesone M. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of bcl2 related genes. Biol Reprod. 2008;78(3):506\u201313. https:\/\/doi.org\/10.1095\/biolreprod.107.063610.","journal-title":"Biol Reprod"},{"issue":"1","key":"651_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2337\/dc12-0166","volume":"36","author":"Y Doi","year":"2013","unstructured":"Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Hata J, et al. Angiopoietin-like protein 2 and risk of type 2 diabetes in a general japanese population: the hisayama study. Diabetes Care. 2013;36(1):98\u2013100. https:\/\/doi.org\/10.2337\/dc12-0166.","journal-title":"Diabetes Care"},{"issue":"2","key":"651_CR22","first-page":"110","volume":"23","author":"Q Xue","year":"2014","unstructured":"Xue Q, Huang X, Hao G. Expression of angptl 1,2 of cumulus cells in patients with polycystic ovary syndrome. Chin J Reprod Med. 2014;23(2):110\u20135.","journal-title":"Chin J Reprod Med"},{"issue":"6","key":"651_CR23","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.018.","journal-title":"Cell Metab"},{"issue":"3","key":"651_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","volume":"10","author":"M Tabata","year":"2009","unstructured":"Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 2009;10(3):178\u201388. https:\/\/doi.org\/10.1016\/j.cmet.2009.08.003.","journal-title":"Cell Metab"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00651-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-020-00651-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00651-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T23:35:59Z","timestamp":1632526559000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00651-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00651-7","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This experiment was approved by the ethics committee of the Henan University of Traditional Chinese Medicine, and a statement on informed consent from the client or owner.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}